Caris Life Sciences, Inc. Common Stock(CAI)— 技術面狀態
數據截至2026-09-21 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades +40.4% vs the 50-day and +45.5% vs the 200-day average, 10.2% below the 52-week high and +116% off the 52-week low; a golden cross printed 4 sessions ago. Computed from daily closes.
Ranked #6 on today’s Directional Flow — Rising fastest list (scan of 2026-09-21).
移動平均線狀態
- 相對20日均線+15.7%
- 相對50日均線+40.4%
- 相對200日均線+45.5%
- 52週區間低於52週高點10.2% · 高於52週低點116%
- 連續走勢連續1個交易日上漲
- 均線交叉黃金交叉(4個交易日前)
- 50日均線交叉股價向上穿越50日均線(31個交易日前)
- 隨機指標%K 91.3 · %D 87.6(黃金交叉)
FAQ · from the current data · as of 2026-09-21
Quick answers
CAI目前的Closelook訊號是什麼?
Uptrend stack intact — Trades +40.4% vs the 50-day and +45.5% vs the 200-day average, 10.2% below the 52-week high and +116% off the 52-week low; a golden cross printed 4 sessions ago. Computed from daily closes.(截至2026-09-21;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
CAI目前是否位於50日與200日均線上方?
截至2026-09-21,Caris Life Sciences, Inc. Common Stock位於50日均線上方(+40.4%),200日均線上方(+45.5%);距20日均線+15.7%。
CAI距52週高點有多遠?
截至2026-09-21,低於52週高點10.2%,高於52週低點116%。
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- RXRX Recursion Pharmaceuticals Incindustry
- HALO Halozyme Therapeutics Incindustry
- SMMT Summit Therapeutics PLCindustry
- GMAB Genmab ASindustry
- CRSP Crispr Therapeutics AGindustry
- IBRX Immunitybio Incindustry
- SRPT Sarepta Therapeutics Incindustry
- TGTX TG Therapeutics Incindustry
- EXEL Exelixis Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- INCY Incyte Corporationindustry